nodes	percent_of_prediction	percent_of_DWPC	metapath
Scopolamine—Depressed level of consciousness—Vandetanib—thyroid cancer	0.0268	0.0316	CcSEcCtD
Scopolamine—Dry eye—Vandetanib—thyroid cancer	0.0256	0.0302	CcSEcCtD
Scopolamine—Dry skin—Vandetanib—thyroid cancer	0.0185	0.0218	CcSEcCtD
Scopolamine—Dysphagia—Vandetanib—thyroid cancer	0.0174	0.0205	CcSEcCtD
Scopolamine—Dysuria—Vandetanib—thyroid cancer	0.0163	0.0192	CcSEcCtD
Scopolamine—Eczema—Sorafenib—thyroid cancer	0.0151	0.0178	CcSEcCtD
Scopolamine—Conjunctivitis—Vandetanib—thyroid cancer	0.0151	0.0178	CcSEcCtD
Scopolamine—Bradycardia—Vandetanib—thyroid cancer	0.0142	0.0167	CcSEcCtD
Scopolamine—Urinary tract disorder—Vandetanib—thyroid cancer	0.0138	0.0162	CcSEcCtD
Scopolamine—Urethral disorder—Vandetanib—thyroid cancer	0.0137	0.0161	CcSEcCtD
Scopolamine—Visual impairment—Vandetanib—thyroid cancer	0.0134	0.0158	CcSEcCtD
Scopolamine—Eye disorder—Vandetanib—thyroid cancer	0.013	0.0154	CcSEcCtD
Scopolamine—Dry skin—Sorafenib—thyroid cancer	0.0125	0.0147	CcSEcCtD
Scopolamine—Arrhythmia—Vandetanib—thyroid cancer	0.0125	0.0147	CcSEcCtD
Scopolamine—Mental disorder—Vandetanib—thyroid cancer	0.0122	0.0144	CcSEcCtD
Scopolamine—Dysphagia—Sorafenib—thyroid cancer	0.0117	0.0139	CcSEcCtD
Scopolamine—Vision blurred—Vandetanib—thyroid cancer	0.0114	0.0135	CcSEcCtD
Scopolamine—Tremor—Vandetanib—thyroid cancer	0.0114	0.0134	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Vandetanib—thyroid cancer	0.0103	0.0121	CcSEcCtD
Scopolamine—Redness—Epirubicin—thyroid cancer	0.0103	0.0121	CcSEcCtD
Scopolamine—Dry mouth—Vandetanib—thyroid cancer	0.0101	0.0119	CcSEcCtD
Scopolamine—Oedema—Vandetanib—thyroid cancer	0.0099	0.0117	CcSEcCtD
Scopolamine—Nervous system disorder—Vandetanib—thyroid cancer	0.00971	0.0115	CcSEcCtD
Scopolamine—Skin disorder—Vandetanib—thyroid cancer	0.00962	0.0113	CcSEcCtD
Scopolamine—Redness—Doxorubicin—thyroid cancer	0.00949	0.0112	CcSEcCtD
Scopolamine—Urinary tract disorder—Sorafenib—thyroid cancer	0.00929	0.011	CcSEcCtD
Scopolamine—Urethral disorder—Sorafenib—thyroid cancer	0.00922	0.0109	CcSEcCtD
Scopolamine—Amblyopia—Epirubicin—thyroid cancer	0.00896	0.0106	CcSEcCtD
Scopolamine—Flushing—Sorafenib—thyroid cancer	0.00873	0.0103	CcSEcCtD
Scopolamine—Fatigue—Vandetanib—thyroid cancer	0.00854	0.0101	CcSEcCtD
Scopolamine—Pain—Vandetanib—thyroid cancer	0.00847	0.00999	CcSEcCtD
Scopolamine—Constipation—Vandetanib—thyroid cancer	0.00847	0.00999	CcSEcCtD
Scopolamine—Arrhythmia—Sorafenib—thyroid cancer	0.0084	0.00991	CcSEcCtD
Scopolamine—Amblyopia—Doxorubicin—thyroid cancer	0.00829	0.00978	CcSEcCtD
Scopolamine—Mental disorder—Sorafenib—thyroid cancer	0.00824	0.00972	CcSEcCtD
Scopolamine—Erythema—Sorafenib—thyroid cancer	0.00819	0.00966	CcSEcCtD
Scopolamine—Abdominal pain—Vandetanib—thyroid cancer	0.00783	0.00923	CcSEcCtD
Scopolamine—Body temperature increased—Vandetanib—thyroid cancer	0.00783	0.00923	CcSEcCtD
Scopolamine—Asthenia—Vandetanib—thyroid cancer	0.00711	0.00838	CcSEcCtD
Scopolamine—Pruritus—Vandetanib—thyroid cancer	0.00701	0.00826	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00692	0.00816	CcSEcCtD
Scopolamine—Dry mouth—Sorafenib—thyroid cancer	0.00682	0.00804	CcSEcCtD
Scopolamine—Nervous system disorder—Sorafenib—thyroid cancer	0.00655	0.00773	CcSEcCtD
Scopolamine—Dizziness—Vandetanib—thyroid cancer	0.00655	0.00772	CcSEcCtD
Scopolamine—Skin disorder—Sorafenib—thyroid cancer	0.00649	0.00765	CcSEcCtD
Scopolamine—Dry eye—Epirubicin—thyroid cancer	0.00639	0.00754	CcSEcCtD
Scopolamine—Vomiting—Vandetanib—thyroid cancer	0.0063	0.00743	CcSEcCtD
Scopolamine—Rash—Vandetanib—thyroid cancer	0.00624	0.00737	CcSEcCtD
Scopolamine—Dermatitis—Vandetanib—thyroid cancer	0.00624	0.00736	CcSEcCtD
Scopolamine—Headache—Vandetanib—thyroid cancer	0.0062	0.00732	CcSEcCtD
Scopolamine—Dry eye—Doxorubicin—thyroid cancer	0.00591	0.00698	CcSEcCtD
Scopolamine—Nausea—Vandetanib—thyroid cancer	0.00588	0.00694	CcSEcCtD
Scopolamine—Fatigue—Sorafenib—thyroid cancer	0.00576	0.00679	CcSEcCtD
Scopolamine—Pain—Sorafenib—thyroid cancer	0.00571	0.00674	CcSEcCtD
Scopolamine—Constipation—Sorafenib—thyroid cancer	0.00571	0.00674	CcSEcCtD
Scopolamine—Eczema—Epirubicin—thyroid cancer	0.00559	0.00659	CcSEcCtD
Scopolamine—Body temperature increased—Sorafenib—thyroid cancer	0.00528	0.00623	CcSEcCtD
Scopolamine—Abdominal pain—Sorafenib—thyroid cancer	0.00528	0.00623	CcSEcCtD
Scopolamine—Eczema—Doxorubicin—thyroid cancer	0.00517	0.0061	CcSEcCtD
Scopolamine—Asthenia—Sorafenib—thyroid cancer	0.00479	0.00565	CcSEcCtD
Scopolamine—Pruritus—Sorafenib—thyroid cancer	0.00473	0.00558	CcSEcCtD
Scopolamine—Dry skin—Epirubicin—thyroid cancer	0.0046	0.00543	CcSEcCtD
Scopolamine—Muscular weakness—Epirubicin—thyroid cancer	0.00443	0.00523	CcSEcCtD
Scopolamine—Dizziness—Sorafenib—thyroid cancer	0.00442	0.00521	CcSEcCtD
Scopolamine—Dysphagia—Epirubicin—thyroid cancer	0.00434	0.00512	CcSEcCtD
Scopolamine—Dry skin—Doxorubicin—thyroid cancer	0.00426	0.00503	CcSEcCtD
Scopolamine—Vomiting—Sorafenib—thyroid cancer	0.00425	0.00501	CcSEcCtD
Scopolamine—Rash—Sorafenib—thyroid cancer	0.00421	0.00497	CcSEcCtD
Scopolamine—Dermatitis—Sorafenib—thyroid cancer	0.00421	0.00496	CcSEcCtD
Scopolamine—Headache—Sorafenib—thyroid cancer	0.00419	0.00494	CcSEcCtD
Scopolamine—Muscular weakness—Doxorubicin—thyroid cancer	0.0041	0.00484	CcSEcCtD
Scopolamine—Dysuria—Epirubicin—thyroid cancer	0.00406	0.00479	CcSEcCtD
Scopolamine—Dysphagia—Doxorubicin—thyroid cancer	0.00402	0.00474	CcSEcCtD
Scopolamine—Nausea—Sorafenib—thyroid cancer	0.00397	0.00468	CcSEcCtD
Scopolamine—Drowsiness—Epirubicin—thyroid cancer	0.00387	0.00457	CcSEcCtD
Scopolamine—Conjunctivitis—Epirubicin—thyroid cancer	0.00376	0.00444	CcSEcCtD
Scopolamine—Dysuria—Doxorubicin—thyroid cancer	0.00376	0.00443	CcSEcCtD
Scopolamine—Sweating—Epirubicin—thyroid cancer	0.00371	0.00438	CcSEcCtD
Scopolamine—Drowsiness—Doxorubicin—thyroid cancer	0.00358	0.00422	CcSEcCtD
Scopolamine—Bradycardia—Epirubicin—thyroid cancer	0.00354	0.00417	CcSEcCtD
Scopolamine—Conjunctivitis—Doxorubicin—thyroid cancer	0.00348	0.00411	CcSEcCtD
Scopolamine—Pharyngitis—Epirubicin—thyroid cancer	0.00345	0.00407	CcSEcCtD
Scopolamine—Sweating—Doxorubicin—thyroid cancer	0.00343	0.00405	CcSEcCtD
Scopolamine—Urinary tract disorder—Epirubicin—thyroid cancer	0.00343	0.00405	CcSEcCtD
Scopolamine—Urethral disorder—Epirubicin—thyroid cancer	0.00341	0.00402	CcSEcCtD
Scopolamine—Visual impairment—Epirubicin—thyroid cancer	0.00335	0.00395	CcSEcCtD
Scopolamine—Bradycardia—Doxorubicin—thyroid cancer	0.00327	0.00386	CcSEcCtD
Scopolamine—Eye disorder—Epirubicin—thyroid cancer	0.00325	0.00383	CcSEcCtD
Scopolamine—Flushing—Epirubicin—thyroid cancer	0.00323	0.0038	CcSEcCtD
Scopolamine—Pharyngitis—Doxorubicin—thyroid cancer	0.00319	0.00376	CcSEcCtD
Scopolamine—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00318	0.00375	CcSEcCtD
Scopolamine—Urethral disorder—Doxorubicin—thyroid cancer	0.00315	0.00372	CcSEcCtD
Scopolamine—Arrhythmia—Epirubicin—thyroid cancer	0.0031	0.00366	CcSEcCtD
Scopolamine—Visual impairment—Doxorubicin—thyroid cancer	0.0031	0.00366	CcSEcCtD
Scopolamine—Mental disorder—Epirubicin—thyroid cancer	0.00304	0.00359	CcSEcCtD
Scopolamine—Erythema—Epirubicin—thyroid cancer	0.00303	0.00357	CcSEcCtD
Scopolamine—Eye disorder—Doxorubicin—thyroid cancer	0.00301	0.00354	CcSEcCtD
Scopolamine—Flushing—Doxorubicin—thyroid cancer	0.00298	0.00352	CcSEcCtD
Scopolamine—Arrhythmia—Doxorubicin—thyroid cancer	0.00287	0.00339	CcSEcCtD
Scopolamine—Vision blurred—Epirubicin—thyroid cancer	0.00285	0.00336	CcSEcCtD
Scopolamine—Mental disorder—Doxorubicin—thyroid cancer	0.00282	0.00332	CcSEcCtD
Scopolamine—Erythema—Doxorubicin—thyroid cancer	0.0028	0.0033	CcSEcCtD
Scopolamine—Agitation—Epirubicin—thyroid cancer	0.00278	0.00328	CcSEcCtD
Scopolamine—Vertigo—Epirubicin—thyroid cancer	0.00272	0.00321	CcSEcCtD
Scopolamine—Vision blurred—Doxorubicin—thyroid cancer	0.00264	0.00311	CcSEcCtD
Scopolamine—Agitation—Doxorubicin—thyroid cancer	0.00257	0.00303	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.00256	0.00302	CcSEcCtD
Scopolamine—Dry mouth—Epirubicin—thyroid cancer	0.00252	0.00297	CcSEcCtD
Scopolamine—Vertigo—Doxorubicin—thyroid cancer	0.00251	0.00297	CcSEcCtD
Scopolamine—Confusional state—Epirubicin—thyroid cancer	0.00249	0.00294	CcSEcCtD
Scopolamine—Oedema—Epirubicin—thyroid cancer	0.00247	0.00291	CcSEcCtD
Scopolamine—Nervous system disorder—Epirubicin—thyroid cancer	0.00242	0.00286	CcSEcCtD
Scopolamine—Tachycardia—Epirubicin—thyroid cancer	0.00241	0.00284	CcSEcCtD
Scopolamine—Skin disorder—Epirubicin—thyroid cancer	0.0024	0.00283	CcSEcCtD
Scopolamine—Hyperhidrosis—Epirubicin—thyroid cancer	0.00239	0.00282	CcSEcCtD
Scopolamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.00237	0.00279	CcSEcCtD
Scopolamine—Dry mouth—Doxorubicin—thyroid cancer	0.00233	0.00275	CcSEcCtD
Scopolamine—Hypotension—Epirubicin—thyroid cancer	0.00231	0.00272	CcSEcCtD
Scopolamine—Confusional state—Doxorubicin—thyroid cancer	0.0023	0.00272	CcSEcCtD
Scopolamine—Oedema—Doxorubicin—thyroid cancer	0.00228	0.00269	CcSEcCtD
Scopolamine—Nervous system disorder—Doxorubicin—thyroid cancer	0.00224	0.00264	CcSEcCtD
Scopolamine—Tachycardia—Doxorubicin—thyroid cancer	0.00223	0.00263	CcSEcCtD
Scopolamine—Skin disorder—Doxorubicin—thyroid cancer	0.00222	0.00262	CcSEcCtD
Scopolamine—Hyperhidrosis—Doxorubicin—thyroid cancer	0.00221	0.0026	CcSEcCtD
Scopolamine—Somnolence—Epirubicin—thyroid cancer	0.00219	0.00259	CcSEcCtD
Scopolamine—Hypotension—Doxorubicin—thyroid cancer	0.00213	0.00252	CcSEcCtD
Scopolamine—Fatigue—Epirubicin—thyroid cancer	0.00213	0.00251	CcSEcCtD
Scopolamine—Pain—Epirubicin—thyroid cancer	0.00211	0.00249	CcSEcCtD
Scopolamine—Constipation—Epirubicin—thyroid cancer	0.00211	0.00249	CcSEcCtD
Scopolamine—Feeling abnormal—Epirubicin—thyroid cancer	0.00203	0.0024	CcSEcCtD
Scopolamine—Somnolence—Doxorubicin—thyroid cancer	0.00203	0.0024	CcSEcCtD
Scopolamine—Fatigue—Doxorubicin—thyroid cancer	0.00197	0.00232	CcSEcCtD
Scopolamine—Pain—Doxorubicin—thyroid cancer	0.00195	0.0023	CcSEcCtD
Scopolamine—Constipation—Doxorubicin—thyroid cancer	0.00195	0.0023	CcSEcCtD
Scopolamine—Body temperature increased—Epirubicin—thyroid cancer	0.00195	0.0023	CcSEcCtD
Scopolamine—Abdominal pain—Epirubicin—thyroid cancer	0.00195	0.0023	CcSEcCtD
Scopolamine—Feeling abnormal—Doxorubicin—thyroid cancer	0.00188	0.00222	CcSEcCtD
Scopolamine—Abdominal pain—Doxorubicin—thyroid cancer	0.00181	0.00213	CcSEcCtD
Scopolamine—Body temperature increased—Doxorubicin—thyroid cancer	0.00181	0.00213	CcSEcCtD
Scopolamine—Asthenia—Epirubicin—thyroid cancer	0.00177	0.00209	CcSEcCtD
Scopolamine—Pruritus—Epirubicin—thyroid cancer	0.00175	0.00206	CcSEcCtD
Scopolamine—Asthenia—Doxorubicin—thyroid cancer	0.00164	0.00193	CcSEcCtD
Scopolamine—Dizziness—Epirubicin—thyroid cancer	0.00163	0.00193	CcSEcCtD
Scopolamine—Pruritus—Doxorubicin—thyroid cancer	0.00162	0.00191	CcSEcCtD
Scopolamine—Vomiting—Epirubicin—thyroid cancer	0.00157	0.00185	CcSEcCtD
Scopolamine—Rash—Epirubicin—thyroid cancer	0.00156	0.00184	CcSEcCtD
Scopolamine—Dermatitis—Epirubicin—thyroid cancer	0.00156	0.00183	CcSEcCtD
Scopolamine—Headache—Epirubicin—thyroid cancer	0.00155	0.00182	CcSEcCtD
Scopolamine—Dizziness—Doxorubicin—thyroid cancer	0.00151	0.00178	CcSEcCtD
Scopolamine—Nausea—Epirubicin—thyroid cancer	0.00147	0.00173	CcSEcCtD
Scopolamine—Vomiting—Doxorubicin—thyroid cancer	0.00145	0.00171	CcSEcCtD
Scopolamine—Rash—Doxorubicin—thyroid cancer	0.00144	0.0017	CcSEcCtD
Scopolamine—Dermatitis—Doxorubicin—thyroid cancer	0.00144	0.0017	CcSEcCtD
Scopolamine—Headache—Doxorubicin—thyroid cancer	0.00143	0.00169	CcSEcCtD
Scopolamine—Nausea—Doxorubicin—thyroid cancer	0.00136	0.0016	CcSEcCtD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—BRAF—thyroid cancer	0.000456	0.00299	CbGpPWpGaD
Scopolamine—SI—Metabolism—PPARG—thyroid cancer	0.000444	0.00292	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TRIM33—thyroid cancer	0.000442	0.00291	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	0.00043	0.00283	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—PTCH1—thyroid cancer	0.000427	0.0028	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—PTCH1—thyroid cancer	0.000425	0.00279	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—PTCH1—thyroid cancer	0.000421	0.00277	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—TSHR—thyroid cancer	0.000421	0.00276	CbGpPWpGaD
Scopolamine—SI—Disease—PTGS2—thyroid cancer	0.000417	0.00274	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—NDUFA13—thyroid cancer	0.000417	0.00274	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	0.000412	0.00271	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—TSHR—thyroid cancer	0.000403	0.00265	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—CHST14—thyroid cancer	0.000392	0.00257	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—SST—thyroid cancer	0.00039	0.00256	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—RXRA—thyroid cancer	0.000389	0.00256	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—SST—thyroid cancer	0.000389	0.00256	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—SST—thyroid cancer	0.000385	0.00253	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—TSHR—thyroid cancer	0.000382	0.00251	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000376	0.00247	CbGpPWpGaD
Scopolamine—CHRM1—GPCR ligand binding—CALCA—thyroid cancer	0.000376	0.00247	CbGpPWpGaD
Scopolamine—CHRM3—GPCR ligand binding—CALCA—thyroid cancer	0.000374	0.00246	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—PPARG—thyroid cancer	0.000373	0.00245	CbGpPWpGaD
Scopolamine—CHRM2—GPCR ligand binding—CALCA—thyroid cancer	0.000371	0.00244	CbGpPWpGaD
Scopolamine—CHRM4—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	0.00037	0.00243	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—TSHR—thyroid cancer	0.000366	0.0024	CbGpPWpGaD
Scopolamine—SI—Disease—PTEN—thyroid cancer	0.000364	0.00239	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00036	0.00236	CbGpPWpGaD
Scopolamine—CHRM5—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	0.000355	0.00233	CbGpPWpGaD
Scopolamine—SI—Metabolism—PTGS2—thyroid cancer	0.000349	0.0023	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CALCB—thyroid cancer	0.000329	0.00216	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CALCB—thyroid cancer	0.000328	0.00215	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—SST—thyroid cancer	0.000327	0.00215	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—PTCH1—thyroid cancer	0.000325	0.00213	CbGpPWpGaD
Scopolamine—SI—Disease—NRAS—thyroid cancer	0.000325	0.00213	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CALCB—thyroid cancer	0.000324	0.00213	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—HPGD—thyroid cancer	0.000316	0.00207	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—CALCA—thyroid cancer	0.000315	0.00207	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—SST—thyroid cancer	0.000313	0.00206	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TRIM33—thyroid cancer	0.000311	0.00205	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—PTCH1—thyroid cancer	0.000311	0.00204	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—MINPP1—thyroid cancer	0.000311	0.00204	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TRIM33—thyroid cancer	0.000311	0.00204	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TCF7L1—thyroid cancer	0.000308	0.00203	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TRIM33—thyroid cancer	0.000307	0.00202	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000307	0.00202	CbGpPWpGaD
Scopolamine—SI—Metabolism—PTEN—thyroid cancer	0.000305	0.002	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—CALCA—thyroid cancer	0.000301	0.00198	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—SST—thyroid cancer	0.000297	0.00195	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TCF7L1—thyroid cancer	0.000295	0.00194	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	0.00029	0.00191	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	0.000289	0.0019	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—NRAS—thyroid cancer	0.000286	0.00188	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CALCA—thyroid cancer	0.000286	0.00188	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—SST—thyroid cancer	0.000284	0.00187	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—TSHR—thyroid cancer	0.000284	0.00186	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—TSHR—thyroid cancer	0.000283	0.00186	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—TSHR—thyroid cancer	0.00028	0.00184	CbGpPWpGaD
Scopolamine—SI—Disease—KRAS—thyroid cancer	0.000279	0.00184	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CALCA—thyroid cancer	0.000274	0.0018	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000264	0.00174	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—NDUFA13—thyroid cancer	0.000264	0.00174	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—CDK1—thyroid cancer	0.000259	0.0017	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—TSHR—thyroid cancer	0.000258	0.00169	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—TSHR—thyroid cancer	0.000257	0.00169	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—PTEN—thyroid cancer	0.000256	0.00168	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—TSHR—thyroid cancer	0.000254	0.00167	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000253	0.00166	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PRKAR1A—thyroid cancer	0.000253	0.00166	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PRKAR1A—thyroid cancer	0.00025	0.00164	CbGpPWpGaD
Scopolamine—CHRM1—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	0.00025	0.00164	CbGpPWpGaD
Scopolamine—CHRM3—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	0.000249	0.00164	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—CHST14—thyroid cancer	0.000249	0.00163	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—CDK1—thyroid cancer	0.000248	0.00163	CbGpPWpGaD
Scopolamine—CHRM2—Regulation of Actin Cytoskeleton—KRAS—thyroid cancer	0.000246	0.00162	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—TPR—thyroid cancer	0.000246	0.00161	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—CP—thyroid cancer	0.000246	0.00161	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—PRKAR1A—thyroid cancer	0.000242	0.00159	CbGpPWpGaD
Scopolamine—SI—Disease—HRAS—thyroid cancer	0.000238	0.00156	CbGpPWpGaD
Scopolamine—ABCB1—HIF-1-alpha transcription factor network—AKT1—thyroid cancer	0.000227	0.00149	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TSHR—thyroid cancer	0.000226	0.00148	CbGpPWpGaD
Scopolamine—CHRM5—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000225	0.00148	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PRKAR1A—thyroid cancer	0.000222	0.00146	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—SST—thyroid cancer	0.000221	0.00145	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—SST—thyroid cancer	0.00022	0.00144	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—PTCH1—thyroid cancer	0.000219	0.00144	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—PTCH1—thyroid cancer	0.000218	0.00143	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—SST—thyroid cancer	0.000218	0.00143	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000216	0.00142	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—PTCH1—thyroid cancer	0.000216	0.00142	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TSHR—thyroid cancer	0.000216	0.00142	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—thyroid cancer	0.000216	0.00142	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PRKAR1A—thyroid cancer	0.000213	0.0014	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—CALCA—thyroid cancer	0.000212	0.00139	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—MEN1—thyroid cancer	0.000212	0.00139	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—CALCA—thyroid cancer	0.000212	0.00139	CbGpPWpGaD
Scopolamine—SI—Disease—AKT1—thyroid cancer	0.00021	0.00138	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—CALCA—thyroid cancer	0.00021	0.00138	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TCF7L1—thyroid cancer	0.000208	0.00137	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TCF7L1—thyroid cancer	0.000207	0.00136	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TCF7L1—thyroid cancer	0.000205	0.00135	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—MEN1—thyroid cancer	0.000203	0.00133	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—HPGD—thyroid cancer	0.0002	0.00132	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—SST—thyroid cancer	0.0002	0.00132	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—SST—thyroid cancer	0.0002	0.00131	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—SST—thyroid cancer	0.000198	0.0013	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—thyroid cancer	0.000193	0.00127	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CALCA—thyroid cancer	0.000193	0.00127	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CALCA—thyroid cancer	0.000192	0.00126	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTCH1—thyroid cancer	0.000192	0.00126	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CALCA—thyroid cancer	0.00019	0.00125	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000186	0.00122	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—thyroid cancer	0.000186	0.00122	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—SLC5A5—thyroid cancer	0.000184	0.00121	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTCH1—thyroid cancer	0.000184	0.00121	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—TPR—thyroid cancer	0.000181	0.00119	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PRKAR1A—thyroid cancer	0.000178	0.00117	CbGpPWpGaD
Scopolamine—SI—Metabolism—AKT1—thyroid cancer	0.000176	0.00115	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—SST—thyroid cancer	0.000175	0.00115	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—thyroid cancer	0.000175	0.00115	CbGpPWpGaD
Scopolamine—CHRM1—Circadian rythm related genes—TP53—thyroid cancer	0.000175	0.00115	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—CDK1—thyroid cancer	0.000174	0.00115	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—CDK1—thyroid cancer	0.000174	0.00114	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—CDK1—thyroid cancer	0.000172	0.00113	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CALCA—thyroid cancer	0.000169	0.00111	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—thyroid cancer	0.000169	0.00111	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—SST—thyroid cancer	0.000168	0.0011	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CALCA—thyroid cancer	0.000162	0.00106	CbGpPWpGaD
Scopolamine—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000158	0.00104	CbGpPWpGaD
Scopolamine—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—thyroid cancer	0.000158	0.00104	CbGpPWpGaD
Scopolamine—ABCB1—Transmembrane transport of small molecules—RXRA—thyroid cancer	0.000155	0.00102	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CDK1—thyroid cancer	0.000153	0.001	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TSHR—thyroid cancer	0.000152	0.001	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TSHR—thyroid cancer	0.000152	0.000996	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TSHR—thyroid cancer	0.00015	0.000987	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PRKAR1A—thyroid cancer	0.00015	0.000983	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PRKAR1A—thyroid cancer	0.000149	0.00098	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PRKAR1A—thyroid cancer	0.000148	0.000971	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CDK1—thyroid cancer	0.000146	0.000962	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—MEN1—thyroid cancer	0.000143	0.00094	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—MEN1—thyroid cancer	0.000143	0.000937	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—MEN1—thyroid cancer	0.000141	0.000928	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—SLC5A5—thyroid cancer	0.000136	0.000892	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—thyroid cancer	0.000129	0.000851	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTCH1—thyroid cancer	0.000129	0.00085	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTCH1—thyroid cancer	0.000129	0.000847	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTCH1—thyroid cancer	0.000128	0.000839	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NRG1—thyroid cancer	0.000123	0.000806	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—SST—thyroid cancer	0.000118	0.000777	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—SST—thyroid cancer	0.000118	0.000775	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NRG1—thyroid cancer	0.000118	0.000772	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—SST—thyroid cancer	0.000117	0.000767	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—TPR—thyroid cancer	0.000115	0.000756	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thyroid cancer	0.000115	0.000756	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—RXRA—thyroid cancer	0.000114	0.000749	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CALCA—thyroid cancer	0.000114	0.000748	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CALCA—thyroid cancer	0.000114	0.000746	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PRKAR1A—thyroid cancer	0.000113	0.000744	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CALCA—thyroid cancer	0.000112	0.000739	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TERT—thyroid cancer	0.00011	0.000724	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TERT—thyroid cancer	0.000106	0.000693	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HIF1A—thyroid cancer	0.000105	0.000692	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CDK1—thyroid cancer	0.000103	0.000677	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CDK1—thyroid cancer	0.000103	0.000675	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CDK1—thyroid cancer	0.000102	0.000669	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HIF1A—thyroid cancer	0.000101	0.000663	CbGpPWpGaD
Scopolamine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thyroid cancer	9.71e-05	0.000638	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—NRAS—thyroid cancer	9.28e-05	0.00061	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—NRAS—thyroid cancer	8.89e-05	0.000584	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—BRAF—thyroid cancer	8.73e-05	0.000573	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—SLC5A5—thyroid cancer	8.61e-05	0.000566	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—BRAF—thyroid cancer	8.36e-05	0.000549	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NRG1—thyroid cancer	8.27e-05	0.000544	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NRG1—thyroid cancer	8.25e-05	0.000542	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NRG1—thyroid cancer	8.17e-05	0.000537	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—KRAS—thyroid cancer	7.99e-05	0.000525	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—KRAS—thyroid cancer	7.65e-05	0.000503	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TERT—thyroid cancer	7.43e-05	0.000488	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TERT—thyroid cancer	7.41e-05	0.000487	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TERT—thyroid cancer	7.33e-05	0.000482	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—RXRA—thyroid cancer	7.24e-05	0.000476	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PPARG—thyroid cancer	7.2e-05	0.000473	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HIF1A—thyroid cancer	7.1e-05	0.000467	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HIF1A—thyroid cancer	7.08e-05	0.000465	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HIF1A—thyroid cancer	7.01e-05	0.000461	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—HRAS—thyroid cancer	6.79e-05	0.000446	CbGpPWpGaD
Scopolamine—CHRM4—GPCR downstream signaling—AKT1—thyroid cancer	6.6e-05	0.000434	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—HRAS—thyroid cancer	6.5e-05	0.000427	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—CCND1—thyroid cancer	6.37e-05	0.000418	CbGpPWpGaD
Scopolamine—CHRM5—GPCR downstream signaling—AKT1—thyroid cancer	6.32e-05	0.000416	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—NRAS—thyroid cancer	6.26e-05	0.000411	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—NRAS—thyroid cancer	6.24e-05	0.00041	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—NRAS—thyroid cancer	6.18e-05	0.000406	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—PTEN—thyroid cancer	6.15e-05	0.000404	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—CCND1—thyroid cancer	6.1e-05	0.000401	CbGpPWpGaD
Scopolamine—CHRM4—Signaling by GPCR—AKT1—thyroid cancer	6e-05	0.000394	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—PTEN—thyroid cancer	5.89e-05	0.000387	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—BRAF—thyroid cancer	5.88e-05	0.000387	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—BRAF—thyroid cancer	5.86e-05	0.000385	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—BRAF—thyroid cancer	5.81e-05	0.000382	CbGpPWpGaD
Scopolamine—CHRM5—Signaling by GPCR—AKT1—thyroid cancer	5.74e-05	0.000377	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTGS2—thyroid cancer	5.67e-05	0.000372	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—NRAS—thyroid cancer	5.48e-05	0.00036	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—KRAS—thyroid cancer	5.39e-05	0.000354	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—KRAS—thyroid cancer	5.37e-05	0.000353	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—KRAS—thyroid cancer	5.32e-05	0.000349	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—NRAS—thyroid cancer	5.25e-05	0.000345	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—PTEN—thyroid cancer	4.94e-05	0.000325	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—KRAS—thyroid cancer	4.72e-05	0.00031	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—HRAS—thyroid cancer	4.58e-05	0.000301	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PPARG—thyroid cancer	4.57e-05	0.0003	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—HRAS—thyroid cancer	4.56e-05	0.0003	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—HRAS—thyroid cancer	4.52e-05	0.000297	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—KRAS—thyroid cancer	4.52e-05	0.000297	CbGpPWpGaD
Scopolamine—CHRM1—GPCR downstream signaling—AKT1—thyroid cancer	4.45e-05	0.000293	CbGpPWpGaD
Scopolamine—CHRM3—GPCR downstream signaling—AKT1—thyroid cancer	4.44e-05	0.000292	CbGpPWpGaD
Scopolamine—CHRM2—GPCR downstream signaling—AKT1—thyroid cancer	4.4e-05	0.000289	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—CCND1—thyroid cancer	4.29e-05	0.000282	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—CCND1—thyroid cancer	4.28e-05	0.000281	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—CCND1—thyroid cancer	4.24e-05	0.000279	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—TP53—thyroid cancer	4.19e-05	0.000276	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—PTEN—thyroid cancer	4.14e-05	0.000272	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—PTEN—thyroid cancer	4.13e-05	0.000271	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—PTEN—thyroid cancer	4.09e-05	0.000269	CbGpPWpGaD
Scopolamine—CHRM1—Signaling by GPCR—AKT1—thyroid cancer	4.04e-05	0.000266	CbGpPWpGaD
Scopolamine—CHRM3—Signaling by GPCR—AKT1—thyroid cancer	4.03e-05	0.000265	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—TP53—thyroid cancer	4.02e-05	0.000264	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—HRAS—thyroid cancer	4.01e-05	0.000264	CbGpPWpGaD
Scopolamine—CHRM2—Signaling by GPCR—AKT1—thyroid cancer	3.99e-05	0.000262	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—HRAS—thyroid cancer	3.84e-05	0.000252	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—NRAS—thyroid cancer	3.7e-05	0.000243	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—NRAS—thyroid cancer	3.69e-05	0.000242	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—NRAS—thyroid cancer	3.65e-05	0.00024	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTGS2—thyroid cancer	3.59e-05	0.000236	CbGpPWpGaD
Scopolamine—CHRM4—Signaling Pathways—AKT1—thyroid cancer	3.54e-05	0.000233	CbGpPWpGaD
Scopolamine—CHRM5—Signaling Pathways—AKT1—thyroid cancer	3.39e-05	0.000223	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—KRAS—thyroid cancer	3.18e-05	0.000209	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—KRAS—thyroid cancer	3.17e-05	0.000208	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—KRAS—thyroid cancer	3.14e-05	0.000206	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—PTEN—thyroid cancer	3.13e-05	0.000206	CbGpPWpGaD
Scopolamine—CHRM3—Metabolism—AKT1—thyroid cancer	2.85e-05	0.000187	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—TP53—thyroid cancer	2.83e-05	0.000186	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—TP53—thyroid cancer	2.82e-05	0.000185	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—TP53—thyroid cancer	2.79e-05	0.000183	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—HRAS—thyroid cancer	2.7e-05	0.000178	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—HRAS—thyroid cancer	2.7e-05	0.000177	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—HRAS—thyroid cancer	2.67e-05	0.000175	CbGpPWpGaD
Scopolamine—CHRM1—Signaling Pathways—AKT1—thyroid cancer	2.39e-05	0.000157	CbGpPWpGaD
Scopolamine—CHRM3—Signaling Pathways—AKT1—thyroid cancer	2.38e-05	0.000156	CbGpPWpGaD
Scopolamine—CHRM2—Signaling Pathways—AKT1—thyroid cancer	2.36e-05	0.000155	CbGpPWpGaD
Scopolamine—ABCB1—Metabolism—AKT1—thyroid cancer	1.81e-05	0.000119	CbGpPWpGaD
